INNOVADERM CRO IS NOW INDERO.

Our Insights

FILTER BY:

FILTER BY:

News

Indero Celebrates 25 Years and Looks to the Future of Clinical Research

News

Indero is Returning to THE Annual USA Rheumatology Event!

News

Indero Showcasing Dermatology Expertise at EADV Congress in Paris

News

Meet Indero at SCDM 2025

News

Indero at EADV 2025—Supporting Innovation in Dermatology

News

Indero at ESDR 2025—Advancing Skin Science

News

Let’s Connect at the BIO 2025 convention in Boston!

News

Indero is heading to the European Dermatology Drug Development Summit 2025 in Berlin!

News

Join Us at EULAR 2025 in Barcelona!

FILTER BY:

Post

Rapid Transcriptomics Brings Actionable Data to Early-Phase Topical Trials

Post

Communication is Key to Unlocking Clinical Trial Success

Post

Lessons From a Mercer-Recognized Best Employer

Post

Effective Patient Recruitment Strategies for Clinical Trials: A Guide for Biotech and Pharmaceutical Sponsors

Post

Early Phase Trials: More Than Just Safety

Post

Top Dermatology Conferences to Attend

Post

Key Advantages of APAC for Sponsors

Post

Interview with Dr. Robert Bissonnette: Indero Introduces New Early Phase 1 Model for Topical NCEs, Shortening Study Duration from 8-12 Weeks to ≀3 Days

how to improve patient recruitment in clinical trials
Post

Innovative Approaches to Patient Recruitment in Clinical Trials

FILTER BY:

FILTER BY:

Webinar

Dr. Robert Bissonnette and Dr. Kim Papp on Shaping the Future of Clinical Research

Webinar

In-Person Breakfast Event at the AAD – Spotlight on Hidradenitis Suppurativa

Webinar

Clinical Trials Information System (CTIS)

Webinar

Tips For a Successful Study in Medical Aesthetics

Webinar

Skin Barrier Dysfunction: Atopic Dermatitis and Beyond

Webinar

The Art of Protocol Writing in Dermatology

Webinar

How to Handle Missing Data in Dermatology Trials

Webinar

Non-invasive methods to study molecular biomarkers in the skin: Tape Stripping and Beyond

FILTER BY:

Subscribe to our newsletter.

Do not miss out on valuable insights and research updates. Join our scientific community today!

This field is for validation purposes and should be left unchanged.

Jeff Smith

Chef de la direction

Jeff Smith, Chef de la direction d’Indero Recherches, apporte prĂšs de 30 ans d’expĂ©rience dans l’industrie pharmaceutique et CRO, s’Ă©tant distinguĂ© par son leadership exceptionnel, sa vision stratĂ©gique et son innovation. L’expertise de Jeff couvre des opĂ©rations mondiales, la gestion de la croissance, ainsi que la promotion d’une culture d’entreprise collaborative. Ses atouts en matiĂšre de crĂ©ation de valeur, de gestion des partenaires et d’opĂ©rations CRO ont toujours contribuĂ© au succĂšs dans ses fonctions prĂ©cĂ©dentes. Sous la direction de Jeff, Indero continue d’étendre ses capacitĂ©s, faisant progresser les connaissances mĂ©dicales et les nouvelles thĂ©rapies en dermatologie et en rhumatologie.

Revolutionize Your Topical Trials

Efficacy insights in days, not months.

 Indero’s Early Phase 1 model enables sponsors to initiate topical studies that detect early pharmacodynamic signals much sooner than traditional phase 1, using microdosing and transcriptomic analysis. This approach reduces preclinical requirements, shortens study duration from 8–12 weeks to ≀3 days, and lowers costs, helping teams make informed go/no-go decisions faster.